BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12820798)

  • 1. Inhibition studies of sulfonamide-containing folate analogs in yeast.
    Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
    Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast.
    Patel O; Karnik K; Macreadie IG
    FEMS Microbiol Lett; 2004 Jul; 236(2):301-5. PubMed ID: 15251211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.
    Iliades P; Meshnick SR; Macreadie IG
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2617-23. PubMed ID: 15215118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfa drug screening in yeast: fifteen sulfa drugs compete with p-aminobenzoate in Saccharomyces cerevisiae.
    Castelli LA; Nguyen NP; Macreadie IG
    FEMS Microbiol Lett; 2001 May; 199(2):181-4. PubMed ID: 11377864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
    Iliades P; Berglez J; Meshnick S; Macreadie I
    Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
    Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
    J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
    Vinnicombe HG; Derrick JP
    Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae.
    Meneau I; Sanglard D; Bille J; Hauser PM
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2610-6. PubMed ID: 15215117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
    Fernley RT; Iliades P; Macreadie I
    Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
    Iliades P; Meshnick SR; Macreadie IG
    Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.
    Nahimana A; Rabodonirina M; Helweg-Larsen J; Meneau I; Francioli P; Bille J; Hauser PM
    Emerg Infect Dis; 2003 Jul; 9(7):864-7. PubMed ID: 12890330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
    Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
    Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax dihydrofolate reductase as a target of sulpha drugs.
    Djapa LY; Zelikson R; Delahodde A; Bolotin-Fukuhara M; Mazabraud A
    FEMS Microbiol Lett; 2006 Mar; 256(1):105-11. PubMed ID: 16487326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
    Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid utilisation related to sulfa drug resistance in Saccharomyces cerevisiae.
    Bayly AM; Berglez JM; Patel O; Castelli LA; Hankins EG; Coloe P; Hopkins Sibley C; Macreadie IG
    FEMS Microbiol Lett; 2001 Nov; 204(2):387-90. PubMed ID: 11731153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulfonamide resistance.
    Levy C; Minnis D; Derrick JP
    Biochem J; 2008 Jun; 412(2):379-88. PubMed ID: 18321242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the bifunctional dihydrofolate synthase-folylpolyglutamate synthase from Plasmodium falciparum; a potential novel target for antimalarial antifolate inhibition.
    Wang P; Wang Q; Yang Y; Coward JK; Nzila A; Sims PF; Hyde JE
    Mol Biochem Parasitol; 2010 Jul; 172(1):41-51. PubMed ID: 20350571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
    Stein CR; Poole C; Kazanjian P; Meshnick SR
    Emerg Infect Dis; 2004 Oct; 10(10):1760-5. PubMed ID: 15504261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of dihydropteroate in Saccharomyces cerevisiae.
    Bayly AM; Macreadie IG
    FEMS Microbiol Lett; 2002 Aug; 213(2):189-92. PubMed ID: 12167536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
    Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
    Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.